RWE Vendor Landscape · CDMO
CDMO Companies in Real-World Evidence
Contract development and manufacturing organizations (CDMOs) build and make the therapies that real-world evidence ultimately measures, across small molecule, biologics and advanced modalities.
The development and manufacturing partners in the RWE ecosystem meet their buyers at RWE Connect 2026 in Boston.
No public pricing. Enquiry-led, no obligation.
By modality
What CDMOs Develop and Manufacture
Contract partners specialise across therapeutic modalities, each with its own science, facilities and quality demands. The strongest cover several.
Evaluation
What Makes a Strong CDMO Partner
Sponsors weigh development and manufacturing partners against a demanding bar. These are the criteria that decide who wins the contract.
Industry trends
What’s Reshaping the CDMO Landscape in 2026
The development and manufacturing market is shifting fast, and it shapes which partners biopharma chooses. These are the forces in play, several of them on the agenda at RWE Connect 2026.
Across the lifecycle
From Preclinical to Commercial Supply
CDMOs support a therapy at every stage, and real-world evidence increasingly informs the decisions made along the way.
The connection
Why CDMOs Engage with Real-World Evidence
CDMOs sit upstream of real-world evidence, yet the two are increasingly connected. Here is where the worlds meet, honestly framed.
The programme
What’s on the Agenda
Two days built around the themes that move real-world evidence forward: the data, the methods, the economics and the decisions it supports. 40+ speakers across keynotes, panels, workshops and the Partnering Lounge.
Formats include keynotes, expert panels, case studies, workshops, the Partnering Lounge and the exhibition. The full session-by-session agenda and speaker line-up are confirmed closer to the event.
Who is in the room
Attendee Breakdown
A senior, focused audience of the buyers who shape development, evidence and partner decisions.
Seniority is confirmed: 150+ attendees, around 60% at Director or VP level and above. The functional mix shown is indicative; confirmed registration splits are shared with sponsors from the live delegate list.
Already on board
Data and Analytics Leaders at RWE Connect 2026
Why RWE Connect
A Generic Pharma Expo vs RWE Connect
CDMOs spend heavily at vast manufacturing and pharma expos. RWE Connect offers something different: direct access to the RWE, HEOR and biopharma decision-makers who influence partner selection and the evidence behind it.
A Generic Pharma Expo
- Enormous halls across every pharma service
- Evidence and RWE buyers barely present
- Booths judged on footfall, not conversations
- Networking left to chance encounters and business cards
- Limited access to senior decision-makers
- No view of who is actually attending
RWE Connect 2026
- 150+ senior RWE, HEOR and biopharma buyers
- Around 60% at Director or VP level and above
- A Partnering Lounge built for pre-scheduled 1:1 meetings
- Meetings booked with the accounts you name
- Access to the people who influence partner selection
- A shared delegate list for warm, targeted follow-up
Why sponsor
Meet the Teams Shaping Development and Evidence
What sponsoring looks like
How a CDMO Wins Business at RWE Connect
Sponsorship here is built around qualified meetings, not just a stand. This is the typical path from sign-up to signed opportunity.
RWE Connect 2026
Put Your Company in Front of the Room
150+ real-world evidence buyers, around 60% at Director or VP level and above, over two days in Boston. Request the prospectus and the team replies within one business day.
- Exhibition space and capability showcases
- Speaking and panel opportunities
- Pre-scheduled 1:1 meetings with the buyers you name
No public pricing. Enquiry-led, no obligation.
CDMO Companies: Common Questions
What are CDMO companies?
Contract development and manufacturing organizations that develop and manufacture drugs and biologics on behalf of pharmaceutical and biotech companies, across small molecule, biologics and advanced modalities.
How do CDMOs relate to real-world evidence?
CDMOs sit upstream of real-world evidence, but increasingly use real-world safety, quality and demand data to inform manufacturing, forecasting and lifecycle decisions, and to support the sponsors whose products generate that evidence.
What modalities do CDMOs cover?
Small molecule, biologics, cell and gene therapy, antibody-drug conjugates, sterile fill-finish, and vaccines and plasma products, across every stage from preclinical to commercial supply.
Which companies are confirmed at RWE Connect 2026?
Confirmed sponsors to date span data and analytics providers including Truveta, Magnolia, Forian and Arcadia. The programme covers the development, manufacturing and lifecycle themes relevant to CDMOs, with 40+ speakers.
Why should a CDMO exhibit or sponsor?
To meet the RWE, HEOR and biopharma decision-makers who influence development-partner selection, and to position alongside the evidence their clients increasingly require. Request the prospectus to discuss options.
Can my company exhibit or sponsor?
Yes. Request the prospectus for exhibition, speaking and pre-scheduled 1:1 meeting options; pricing is shared on enquiry.
When and where is RWE Connect 2026?
14 to 15 October 2026 at the Hampton Inn by Hilton, Boston Seaport District, Boston, MA.
What should sponsors look for in a CDMO?
A clean quality and compliance record, capacity and scalability, proven modality expertise, regulatory and CMC support, supply resilience, and modern manufacturing technology.
What is the difference between a CDMO and a CRO?
A CDMO develops and manufactures the product, while a CRO runs the research and clinical trials. Some organizations offer both under one roof.
How is real-world evidence changing manufacturing decisions?
Real-world safety, demand and outcomes data increasingly inform capacity planning, demand forecasting, and lifecycle and post-market decisions that manufacturing partners help fulfil.
How is RWE Connect different from a generic pharma expo?
RWE Connect gives direct access to senior RWE, HEOR and biopharma buyers through a Partnering Lounge built for pre-scheduled 1:1 meetings, with sponsorship measured in qualified pipeline rather than booth footfall.
What do CDMO sponsors get at RWE Connect 2026?
Exhibition space and a capability showcase, speaking and panel opportunities, pre-scheduled 1:1 meetings with the accounts you name, the delegate list for follow-up, and brand exposure to 150+ real-world evidence buyers.
